AI
KIN

Ariel Investments’s Kindred Biosciences, Inc. KIN Stock Holding History

Ariel Investments’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,159,169
Closed -$5.76M – 133
2021
Q1 		$5.76M Sell
1,159,169
-769,807
-40% -$3.72M 0.06% 98
2020
Q4 		$8.31M Buy
1,928,976
+243,470
+14% +$990K 0.09% 94
2020
Q3 		$7.23M Buy
1,685,506
+151,694
+10% +$634K 0.11% 94
2020
Q2 		$6.89M Sell
1,533,812
-242,665
-14% -$1.08M 0.1% 99
2020
Q1 		$7.11M Sell
1,776,477
-5,293
-0.3% -$45K 0.12% 95
2019
Q4 		$15.1M Sell
1,781,770
-125,015
-7% -$975K 0.19% 85
2019
Q3 		$13.1M Sell
1,906,785
-942,023
-33% -$6.91M 0.17% 86
2019
Q2 		$23.7M Buy
2,848,808
+230,768
+9% +$1.99M 0.3% 79
2019
Q1 		$24M Buy
2,618,040
+621,234
+31% +$6.31M 0.3% 81
2018
Q4 		$21.9M Sell
1,996,806
-179,206
-8% -$2.26M 0.3% 81
2018
Q3 		$30.4M Sell
2,176,012
-42,600
-2% -$576K 0.34% 78
2018
Q2 		$23.6M Buy
2,218,612
+456,783
+26% +$4.45M 0.27% 86
2018
Q1 		$15.2M Sell
1,761,829
-193,723
-10% -$1.7M 0.17% 97
2017
Q4 		$18.5M Sell
1,955,552
-384,571
-16% -$3M 0.21% 93
2017
Q3 		$18.4M Buy
2,340,123
+378,211
+19% +$2.84M 0.21% 90
2017
Q2 		$16.9M Sell
1,961,912
-1,014,410
-34% -$7.28M 0.2% 94
2017
Q1 		$21M Sell
2,976,322
-964,537
-24% -$6.04M 0.25% 87
2016
Q4 		$16.7M Buy
3,940,859
+105,696
+3% +$512K 0.2% 96
2016
Q3 		$19.1M Buy
3,835,163
+139,587
+4% +$590K 0.23% 88
2016
Q2 		$13.1M Buy
3,695,576
+108,015
+3% +$397K 0.16% 102
2016
Q1 		$12.4M Buy
3,587,561
+1,089,382
+44% +$3.85M 0.15% 105
2015
Q4 		$8.49M Buy
2,498,179
+747,955
+43% +$3.47M 0.1% 121
2015
Q3 		$9.1M Buy
1,750,224
+537,865
+44% +$3.32M 0.11% 113
2015
Q2 		$8.27M Buy
1,212,359
+928,759
+327% +$6.59M 0.09% 132
2015
Q1 		$2.02M Buy
283,600
+149,175
+111% +$1.03M 0.02% 175
2014
Q4 		$1M Buy
+134,425
New +$1.14M 0.01% 185

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Ariel Investments's KIN Position: Q2 2021 in Review

Ariel Investments sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 1,159,169 shares — an estimated $5.76M sold.

Ariel Investments first reported a position in KIN in Q4 2014 and held it in 26 quarters. The position peaked at $30.4M in Q3 2018. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

  • Ariel Investments reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ariel Investments sold 1,159,169 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $5.76M.
  • Ariel Investments first reported a position in Kindred Biosciences, Inc. in Q4 2014 and held it in 26 quarters.
  • Ariel Investments's Kindred Biosciences, Inc. position peaked at $30.4M in Q3 2018.
  • 87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Ariel Investments's 13F filing for Q2 2021, filed 13 Aug 2021.